CDX2 and lung carcinoma: Mucinous AC is the diagnostically most challenging group of primary lung cancers, and mainly data on CDX2 and CK20 is found in the literature, with 0–10% and 31–60% positive cases, respectively, in studies reporting both markers [10, 12, 47].